| Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial‐to‐mesenchymal transition P Roepman, A Schlicker, J Tabernero, I Majewski, S Tian, V Moreno, ... International journal of cancer 134 (3), 552-562, 2014 | 400 | 2014 |
| Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis U Nitsche, A Zimmermann, C Späth, T Müller, M Maak, T Schuster, ... Annals of surgery 258 (5), 775-783, 2013 | 293 | 2013 |
| Gut microbiota modulate T cell trafficking into human colorectal cancer E Cremonesi, V Governa, JFG Garzon, V Mele, F Amicarella, MG Muraro, ... Gut 67 (11), 1984-1994, 2018 | 219 | 2018 |
| Effect of preoperative radio (chemo) therapy on long-term functional outcome in rectal cancer patients: a systematic review and meta-analysis M Loos, P Quentmeier, T Schuster, U Nitsche, R Gertler, A Keerl, T Kocher, ... Annals of surgical oncology 20, 1816-1828, 2013 | 202 | 2013 |
| Intra-operative wound irrigation to reduce surgical site infections after abdominal surgery: a systematic review and meta-analysis TC Mueller, M Loos, B Haller, AL Mihaljevic, U Nitsche, D Wilhelm, ... Langenbeck's archives of surgery 400, 167-181, 2015 | 166 | 2015 |
| Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging S Meding, U Nitsche, B Balluff, M Elsner, S Rauser, C Schöne, M Nipp, ... Journal of proteome research 11 (3), 1996-2003, 2012 | 158 | 2012 |
| Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer M Maak, I Simon, U Nitsche, P Roepman, M Snel, AM Glas, T Schuster, ... Annals of surgery 257 (6), 1053-1058, 2013 | 155 | 2013 |
| Blood‐based detection of RAS mutations to guide anti‐EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue‐based RAS testing W Schmiegel, RJ Scott, S Dooley, W Lewis, CJ Meldrum, P Pockney, ... Molecular oncology 11 (2), 208-219, 2017 | 150 | 2017 |
| Tissue‐based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer S Meding, B Balluff, M Elsner, C Schöne, S Rauser, U Nitsche, M Maak, ... The Journal of pathology 228 (4), 459-470, 2012 | 144 | 2012 |
| Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling N Aznar, KK Midde, Y Dunkel, I Lopez-Sanchez, Y Pavlova, A Marivin, ... Elife 4, e07091, 2015 | 124 | 2015 |
| Prediction of prognosis is not improved by the seventh and latest edition of the TNM classification for colorectal cancer in a single-center collective U Nitsche, M Maak, T Schuster, B Künzli, R Langer, J Slotta-Huspenina, ... Annals of surgery 254 (5), 793-801, 2011 | 113 | 2011 |
| Resectability after first-line FOLFIRINOX in initially unresectable locally advanced pancreatic cancer: a single-center experience U Nitsche, P Wenzel, JT Siveke, R Braren, K Holzapfel, AM Schlitter, ... Annals of surgical oncology 22, 1212-1220, 2015 | 103 | 2015 |
| Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer K Malinowsky, U Nitsche, KP Janssen, FG Bader, C Späth, E Drecoll, ... British journal of cancer 110 (8), 2081-2089, 2014 | 102 | 2014 |
| Right sided colon cancer as a distinct histopathological subtype with reduced prognosis U Nitsche, F Stögbauer, C Späth, B Haller, D Wilhelm, H Friess, FG Bader Digestive surgery 33 (2), 157-163, 2016 | 99 | 2016 |
| Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer U Nitsche, R Rosenberg, A Balmert, T Schuster, J Slotta-Huspenina, ... Annals of surgery 256 (5), 763-771, 2012 | 84 | 2012 |
| The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated β-catenin by sequestering TCF4 to the nuclear membrane A Loregger, M Grandl, R Mejías-Luque, M Allgäuer, K Degenhart, ... Science signaling 8 (393), ra90-ra90, 2015 | 82 | 2015 |
| High HSP27 and HSP70 expression levels are independent adverse prognostic factors in primary resected colon cancer K Bauer, U Nitsche, J Slotta-Huspenina, E Drecoll, CH von Weyhern, ... Cellular oncology 35, 197-205, 2012 | 78 | 2012 |
| Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European … RS Croner, CI Geppert, FG Bader, U Nitsche, C Späth, R Rosenberg, ... British journal of cancer 110 (10), 2544-2550, 2014 | 74 | 2014 |
| Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer L Kistner, D Doll, A Holtorf, U Nitsche, KP Janssen Oncotarget 8 (52), 89998, 2017 | 68 | 2017 |
| Tumor-specific targeting of pancreatic cancer with Shiga toxin B-subunit M Maak, U Nitsche, L Keller, P Wolf, M Sarr, M Thiebaud, R Rosenberg, ... Molecular cancer therapeutics 10 (10), 1918-1928, 2011 | 68 | 2011 |
